| Description | Fulranumab, a human IgG2 monoclonal antibody targeting nerve growth factor (NGF), is utilized in pain research [1]. |
| In vitro | Fulranumab（200 μg/mL；60分钟）能够完全抑制10 ng/mL的抗Fulranumab猴多克隆抗体，并且对100及1,000 ng/mL的抗Fulranumab抗体具有超过90%的抑制效果[1]。 |
| molecular weight | N/A |
| CAS | 902141-80-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |